Anuh Pharma Re-appoints Ankit Kishor Chande as Cost Auditor

Anuh Pharma Ltd's Board of Directors, in its meeting on May 20, 2026, approved the re-appointment of Ankit Kishor Chande as Cost Auditor for the financial year 2026-27. The board also approved audited financial results for the year ended March 31, 2026, recommended a dividend of ₹1.50 per equity share, and re-appointed directors Mr. Bipin Nemchand Shah and Mr. Arun Lalchand Todarwal. Additionally, Mr. P. N. Rao was appointed as General Manager - Quality, and M/s. RMJ & Associates LLP was appointed as Internal Auditors. The board also approved the re-classification of certain promoter group shareholders to the public category and scheduled the 66th Annual General Meeting for August 12, 2026.